Ten financial analysts have updated their short term price target for Exact Sciences, the company that developed Cologuard, according to an MFI report.
The company's short term price target estimate is $29, according to the report. On the low end, the price target could be $12. On the high end, the price target could be $37, according to the report.
Exact Sciences has a market cap of $2.03 billion.